Sitafloxacin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sitafloxacin
Sitafloxacin.png
Systematic (IUPAC) name
7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid
Clinical data
Legal status
  • Prescription only
Routes Oral
Identifiers
CAS number 127254-12-0 N
ATC code J01MA21
PubChem CID 461399
ChemSpider 405945 YesY
UNII 3GJC60U4Q8 N
ChEMBL CHEMBL108821 YesY
Chemical data
Formula C19H18ClF2N3O3 
Mol. mass 409.81
 N (what is this?)  (verify)

Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.

See also[edit]

References[edit]

  1. ^ Anderson, DL. (Jul 2008). "Sitafloxacin hydrate for bacterial infections.". Drugs Today (Barc) 44 (7): 489–501. doi:10.1358/dot.2008.44.7.1219561. PMID 18806900. 

Further reading[edit]

External links[edit]